Clinical Trial

A Multi-center Retrospective Study of INO Treating B-ALL

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This multi-center retrospective study aims to evaluate the efficacy and safety of inotuzumab ozogamicin in adults B-ALL of different subgroups. This study is a retrospective study. Data will be collected from Electronic Medical Record, interventions will not be implemented on patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Trial Details
NCT Number NCT07238907
Lead Sponsor Ruijin Hospital
Conditions Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL), Inotuzumab Ozogamicin, Venetoclax
Enrollment 102 participants
Start Date 2022-06-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-25